Keasling: Synthetic Biology Class

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Tentative Schedule)
(Tentative Schedule)
Line 48: Line 48:
#**Spring Break
#**Spring Break
#Ethical, Legal and Policy implications of Synthetic Biology
#Ethical, Legal and Policy implications of Synthetic Biology
-
#*4/5 Blue Heron - John Mulligan [[Slides]]
+
#*4/5 Blue Heron - John Mulligan [[Media:file.ogg]]
#**DNA Synthesis technology, government and self regulation of synthesis technology.
#**DNA Synthesis technology, government and self regulation of synthesis technology.
#*4/12 Pilar Ossorio
#*4/12 Pilar Ossorio

Revision as of 15:49, 5 April 2006

Implications and Applications of Synthetic Biology

General Info

Contents

Spring 2006

Instructors: Jay Keasling, Adam Arkin GSIs: Howard Chou, Yasuo Yoshikuni.

Logistics: Lecture: 2 hours, 8-10 AM Wednesdays Discussion: 1 hour per week date/time TBA

Grading: Group Project 90%, Class Participation 10%

Office hours: TBA

Tentative Schedule

Course Modules:

  1. Introduction to Synthetic Biology
    • 1/17 Introduction, Basis for Synthetic Biology - Jay Keasling
      • Synthetic circuits, Elowitz' repressilator, foundations of genetic engineering, cloning. Enabling technologies: synthesis and sequencing.
    • 1/25 Synthetic Biology and Intellectual Property - Steve Maurer
    • 2/1 Modeling and Design of Synthetic Systems - Adam Arkin
      • Genetic models, stochastic and continuous simulations, adaption of circuit methods to SB. BioJADE design tool.
      • References Questions
    • 2/8 Projects: Challenges and Techniques - Keasling
  2. Applications of Synthetic Biology
    • 2/15 Synthetic Biology in Production - Building Artemisinin - Neil Renninger
      • Amyris will discuss the development of Artemisinin and related compounds, their discovery and commercialization approach.
      • References Questions
    • 2/22 Synthetic Biology for Energy Production - Alex Farrell
      • References Questions
      • Current and future platforms for synthetic energy, economic and thermodynamics of energy production and distribution.
    • 3/1 Bioshield - Steve Maurer
    • 3/8 Marine Derived Compounds and Development - William Gerwick
    • 3/15 "Dual-Use" approaches - Lisa Conte, Napo Pharmaceuticals
      • Pathway development for high-value products, and for easy, cheap deployment in the developing world.
      • References Questions
    • 3/22 Final Project Planning and Discussions
      • Spring Break
  3. Ethical, Legal and Policy implications of Synthetic Biology
    • 4/5 Blue Heron - John Mulligan Media:file.ogg
      • DNA Synthesis technology, government and self regulation of synthesis technology.
    • 4/12 Pilar Ossorio
      • Ethics and Synthetic Biology
    • 4/19 Rogert Brent, Molecular Science Institute and Michael Nacht GSSP
      • National security implications of genetically-engineered pathogens
    • 4/26, 5/3 Final Project Presentations

Group Project Ideas

  1. Dual-use strategies: Identify a synthetic biology “platform” or product with “dual-use” applications for both developed and developing country markets
  2. Energy: What is the energy balance of proposed schemes to produce biofuels from genetically-engineered organisms? What are the relevant technical targets that would need to be met for bioenergy to make sense from an economic and thermodynamic point of view?
  3. Marine biotechnology: Marine natural products represent a largely untapped and promising resource for drug development. As scientists with the Harbor Branch Oceanographic Institution observe:

The marine environment may contain over 80% of the world's plant and animal species, and during the past decade over 5000 novel compounds have been isolated from marine organisms. The diversity of chemical compounds in the marine environment may be due in part to the extreme competition among organisms for space and resources … It is hypothesized that sessile marine organisms (for example, sponges, octocorals, tunicates and algae), have developed a diverse array of chemical compounds known as "secondary metabolites" or natural products for defense and competition.

It is worth noting that this research group alone has discovered 235 bioactive compounds and has had over 117 patents issued over the last 10 years.

Researchers in synthetic biology may be in a position to increase the payoff from this research. Once pharmaceuticals (or possibly specialty chemicals) have been derived from marine natural products, “synthetic biology” approaches developed at Berkeley could lower the cost of producing them at high volumes. This, in turn, would increase the economic and social value that we place on marine biodiversity, in addition to its incalculable intrinsic value. Potential projects:

a. Develop a list of the most promising pharmaceuticals, specialty chemicals, etc. that could be biosynthetically derived using genes from marine organisms. Identify current stage of commercialization. [Examples discussed in the literature include: a cancer therapy made from algae; a painkiller derived from the toxins in cone snail venom; anti-viral drugs Ara-A and AAZT and anti-cancer agent Ara-C developed from a Caribbean coral reef sponge; and Dolostatin 10 (extracted from an Indian Ocean sea hare and undergoing clinical trials for the treatment of breast cancer, tumours, and leukemia. A publication called Natural Products Report has review articles on marine and other natural products. See http://www.rsc.org/Publishing/Journals/NP/index.asp

b. Determine whether any of these are candidates for cost-effective biosynthesis using existing platforms (e.g. pathways for isoprenoids)?

c. Does an analysis of possible high-value marine products for biosynthesis suggest new pathways that would produce precursors for a broad range of them?

d. What models exist to re-invest some of the revenue generated from marine products into marine biodiversity efforts?

Group Project Information

Each group will consist of 3 or 4 people and will hand in a 10-15 page (before the addition of figures) single-spaced paper on the last day of class. Each group will also give a 10-15 minute presentation about their project during one of the final discussion sections.

The format of the paper will be similar to that of a grant. Each group will pick a project idea related to synthetic biology and include discussions about the following topics in their report:


1) Give a brief overview of the project idea.

2) What has already been done related to your project idea? Discuss past or existing research related to your idea.

3) What are you trying to accomplish? What is the purpose/goal of your idea?

4) Why is your project important? Remember, this is a grant, and you are trying to persuade the board to fund your project.

5) How would you go about trying to achieve your idea? Discuss experimental protocols or how you would develop platform technologies to test/build your idea.

6) Discuss what parts of your project will be hardest to achieve.

7) Discuss the timeframe required to achieve your project. Feel free to provide milestones - try to be realistic. Could your project be achieved with existing technologies or would you require new technologies (which may extend the time required to achieve your idea)?

8) What are potential applications for your idea?

9) What are the ethical/social issues/impacts of your idea?


You are not limited to topics above, but you should cover all of them in your paper. Please provide references.

Please email howardc@berkeley.edu with your groups and project ideas by March 8.

Personal tools